Patent details

EP4045533 Title: HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)

Basic Information

Publication number:
EP4045533
PCT Application Number:
US2021024215
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP217194620
PCT Publication Number:
WO2021195418
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)
French Title of Invention:
ANTICORPS MONOCLONAUX HUMAINS CONTRE LE SYNDROME RESPIRATOIRE AIGU SEVERE CORONAVIRUS 2 (SARS-COV-2)
German Title of Invention:
MENSCHLICHE MONOKLONALE ANTIKÖRPER GEGEN DAS SCHWERE AKUTE ATEMWEGSSYNDROM CORONAVIRUS 2 (SARS-COV-2)
SPC Number:

Dates

Filing date:
25/03/2021
Grant date:
15/11/2023
EP Publication Date:
24/08/2022
PCT Publication Date:
30/09/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/11/2023
EP B1 Publication Date:
15/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/03/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/11/2023
 
 

Name:
Vanderbilt University
Address:
305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240, United States (US)

Agent

Name:
ARONOVA S.A.
From:
31/01/2024
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
CROWE, James E., Jr.
Address:
United States (US)

2

Name:
ZOST, Seth
Address:
United States (US)

3

Name:
CARNAHAN, Robert
Address:
United States (US)

4

Name:
GILCHUK, Pavlo
Address:
United States (US)

Priority

1

Priority Number:
202063000299 P
Priority Date:
26/03/2020
Priority Country:
United States (US)

2

Priority Number:
202063002896 P
Priority Date:
31/03/2020
Priority Country:
United States (US)

3

Priority Number:
202063003716 P
Priority Date:
01/04/2020
Priority Country:
United States (US)

4

Priority Number:
202063023545 P
Priority Date:
12/05/2020
Priority Country:
United States (US)

5

Priority Number:
202063024248 P
Priority Date:
13/05/2020
Priority Country:
United States (US)

6

Priority Number:
202063024204 P
Priority Date:
13/05/2020
Priority Country:
United States (US)

7

Priority Number:
202063027173 P
Priority Date:
19/05/2020
Priority Country:
United States (US)

8

Priority Number:
202063037984 P
Priority Date:
11/06/2020
Priority Country:
United States (US)

9

Priority Number:
202063040224 P
Priority Date:
17/06/2020
Priority Country:
United States (US)

10

Priority Number:
202063040246 P
Priority Date:
17/06/2020
Priority Country:
United States (US)

11

Priority Number:
202163142196 P
Priority Date:
27/01/2021
Priority Country:
United States (US)

12

Priority Number:
202163161890 P
Priority Date:
16/03/2021
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/10; G01N 33/569; G01N 33/577; A61K 39/00;

Publication

European Patent Bulletin

1

Issue number:
202346
Publication date:
15/11/2023
Description:
Grant (B1)

2

Issue number:
202351
Publication date:
20/12/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/02/2025
Last Annual Fee Paid Number:
5
Last Annual Fee Paid Amount:
52 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
31/01/2024 Power Of Attorney 1
31/01/2024 Outgoing Correspondence 1